Browsing: NEWS

1) Findings: Insights and developments globally on the subject.
2) Companies: Updates and progress reports on member companies.
3) Industry: Important developments from throughout the field.

Thermo Fisher Scientific’s Aerosol Sense Sampler was announced this week (March 24th). It detects a variety of airborne pathogens, including the coronavirus. The Aerosol Sampler is about the size of a toaster oven. It sucks in ambient air and trapped airborne virus particles — if there were any to be found — into  a specialized cartridge. Daily removal of the cartridge then delivered to laboratory for analysis. At $4,995, AerosolSense is reputed to be simpler and more accessible and will enable collection of air samples “by almost anyone” according to observers. One device can cover about 2000 sf. Experts field…

Read More

LOS ANGELES (March 16, 2021) – XPRIZE announced today the five winning teams in the $6M XPRIZE Rapid Covid Testing competition to create high-quality, affordable COVID-19 testing to help society safely reopen and return to everyday activities. Chosen by an independent panel of judges, the grand prize winning solutions are radically affordable compared to what is currently available on the market; and are comparable to commercial offerings at measuring sensitivity, specificity and limit of detection, with a maximum turnaround time of 12 hours from sample to result.  The winning teams are: Reliable LFC, LLC, Antigen Testing, Carlsbad, United States ChromaCode,…

Read More

With many countries, such as England and Germany, choosing to re-impose stringent lockdowns amidst a third wave of coronavirus infections, the incentive for businesses to find alternative ways to continue operating is higher than ever. Given that mask-wearing and social distancing are less viable in winter temperatures, the question of indoor air purification presents itself as an enticing offer for businesses that typically rely on crowded indoor spaces, which carry a high risk for the spread of COVID-19 through aerosolization and direct contact.  Many big manufacturers of air purifiers, such as Philips, Molekule and Dyson, have been capitalizing on this trend and marketing their…

Read More

Earlier this month, Kontrol Energy’s BioCloud technology received a two million dollar investment from the Ontario government. Kontrol, a Canadian energy company with international collaborators, was founded in 2015, and has made a name for itself through it’s use of technological innovation to address modern problems, such as energy efficiency, air quality and carbon emissions.    Kontrol’s new BioCloud technology is a system designed to detect the ambient presence of COVID-19 in indoor air, and marks the company’s first shift to pandemic era solutions. While coronavirus air testing has recently experienced a technological boom, with companies such as eurofins, AssuredBio, and PathogenDx offering their own air testing technologies, the BioCloud system stands out as the sole…

Read More

NEW YORK | October 14, 2020 –A new report by the Duke-Margolis Center provides the first application of a detailed framework to provide guidance on how best to screen for, and stop or reduce the spread of, Covid-19 (SARS-CoV-2) in schools. The report, Risk Assessment and Testing Considerations for Reducing SARS-CoV-2 Transmission in K-12 Schools, is the first-of-its-kind to offer a risk assessment and testing guidance that can be adapted to reflect the risk of Covid-19 in a school’s community. It also considers the benefits of transmission reduction alongside the costs of testing and of managing “false positive” results. As…

Read More

Fluidigm COVID-19 Campus Safeguard Program Improves Availability of Noninvasive, Saliva-Based SARS-CoV-2 Tests for Higher Education Institutions. SOUTH SAN FRANCISCO, Calif., Oct. 08,  Fluidigm Corporation (Nasdaq:FLDM), announced a program to expand availability of Fluidigm® COVID-19 tests for U.S. colleges and universities. The Fluidigm COVID-19 Campus Safeguard Program will provide millions of noninvasive, saliva-based tests for the SARS-CoV-2 virus to qualifying institutions at a cost as low as $5 per test. The Advanta™ Dx SARS-CoV-2 RT-PCR Assay on the high-throughput Fluidigm Biomark™ HD system features an integrated testing platform and a reliable supply chain and can be easily combined with commonly available…

Read More

Singapore has developed an event testing approach to make possible large events, weddings,  and conferences.  The pilot program will run from late October until December will utilize antigen rapid tests (ARTs) for the pre-event testing, which can return “fairly accurate” results within about half an hour, according to the Ministry of Health (MOH). The ART results will be valid for 24 hours from the time of the swab, and it must be valid at the point of entry until the end of the event, said MOH in a technical briefing on the matter. According to MOH officials:  “If you go…

Read More

The Washington Post has produced an exceptional work on vaccines and their progress.  It does a wonderful job describing the complexity of vaccine development using infographics. Some of the key points. Researchers in the United States set an audacious goal in January to develop a coronavirus vaccine within 12 to 18 months. This would be a world record. The mumps vaccine is considered to be the fastest to move, in four years, from scientific concept to approval in 1967. The quest for an HIV vaccine continues, 36 years and counting. Coronavirus vaccines are moving much faster, partly because governments are taking on the…

Read More